• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过免疫印迹法检测感染和未感染受试者血清标本中抗肺炎支原体黏附蛋白P1的抗体。

Detection of antibodies to Mycoplasma pneumoniae adhesion P1 in serum specimens from infected and non-infected subjects by immunoblotting.

作者信息

Rastawicki W, Räty R, Kleemola M

机构信息

Department of Bacteriology, National Institute of Hygiene, Warsaw, Poland.

出版信息

Diagn Microbiol Infect Dis. 1996 Nov-Dec;26(3-4):141-3. doi: 10.1016/s0732-8893(96)00216-7.

DOI:10.1016/s0732-8893(96)00216-7
PMID:9078450
Abstract

Paired serum specimens from 17 patients with Mycoplasma pneumoniae infection, as demonstrated by a rise in complement fixation (CF) antibody titer and 14 single sera, negative in the CF test, were tested for the presence of Ig A, Ig G, and Ig M antibodies to a polypeptide with a molecular weight of 170 KDa (P1) in an immunoblot assay. In acute phase sera, collected in the 1st week of the disease, frequency of occurrence of the antibodies against P1 protein did not exceed 18%. Two to three weeks later, Ig A antibodies were detectable in 82.4%, Ig M in 76.5%, and Ig G antibodies in all convalescent phase sera. No sera negative in the CF test (titer < 4) had antibodies against M. pneumoniae adhesin P1.

摘要

对17例肺炎支原体感染患者的配对血清标本(通过补体结合(CF)抗体滴度升高得以证实)以及14份CF试验阴性的单份血清,采用免疫印迹法检测针对分子量为170 kDa的多肽(P1)的IgA、IgG和IgM抗体。在疾病第1周采集的急性期血清中,针对P1蛋白的抗体出现频率不超过18%。两到三周后,在所有恢复期血清中,82.4%可检测到IgA抗体,76.5%可检测到IgM抗体,所有血清均可检测到IgG抗体。CF试验阴性(滴度<4)的血清中没有抗肺炎支原体黏附素P1的抗体。

相似文献

1
Detection of antibodies to Mycoplasma pneumoniae adhesion P1 in serum specimens from infected and non-infected subjects by immunoblotting.通过免疫印迹法检测感染和未感染受试者血清标本中抗肺炎支原体黏附蛋白P1的抗体。
Diagn Microbiol Infect Dis. 1996 Nov-Dec;26(3-4):141-3. doi: 10.1016/s0732-8893(96)00216-7.
2
[Evaluation of the usefulness of using western immunoblotting for testing humoral immune response to Mycoplasma pneumoniae antigens during natural infection in humans].[评估蛋白质免疫印迹法在检测人类自然感染肺炎支原体抗原时体液免疫反应中的实用性]
Med Dosw Mikrobiol. 1996;48(1-2):39-48.
3
Immunoblotting patterns with Mycoplasma pneumoniae of serum specimens from infected and non-infected subjects.感染和未感染受试者血清标本与肺炎支原体的免疫印迹模式。
J Med Microbiol. 1992 May;36(5):341-6. doi: 10.1099/00222615-36-5-341.
4
Antibody response to GroEL varies in patients with acute Mycoplasma pneumoniae infection.急性肺炎支原体感染患者对GroEL的抗体反应各不相同。
FEMS Immunol Med Microbiol. 2005 Mar 1;43(3):399-406. doi: 10.1016/j.femsim.2004.10.009.
5
Immune response to Mycoplasma pneumoniae P1 and P116 in patients with atypical pneumonia analyzed by ELISA.通过酶联免疫吸附测定法分析非典型肺炎患者对肺炎支原体P1和P116的免疫反应。
BMC Microbiol. 2004 Feb 5;4:7. doi: 10.1186/1471-2180-4-7.
6
Comparison of MYCOPLASMELISA with complement fixation test for measurement of antibodies to Mycoplasma pneumoniae.用于检测肺炎支原体抗体的支原体酶联免疫吸附测定法与补体结合试验的比较。
Diagn Microbiol Infect Dis. 1986 Feb;4(2):139-45. doi: 10.1016/0732-8893(86)90148-3.
7
Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum.用于检测人血清中肺炎支原体抗体的补体结合分析及商业酶免疫测定法
Clin Diagn Lab Immunol. 2000 Sep;7(5):778-80. doi: 10.1128/CDLI.7.5.778-780.2000.
8
Immunodominant proteins P1 and P40/P90 from human pathogen Mycoplasma pneumoniae.来自人类病原体肺炎支原体的免疫优势蛋白 P1 和 P40/P90。
Nat Commun. 2020 Oct 14;11(1):5188. doi: 10.1038/s41467-020-18777-y.
9
Molecular mimicry by Mycoplasma pneumoniae to evade the induction of adherence inhibiting antibodies.肺炎支原体通过分子模拟来逃避诱导黏附抑制抗体。
J Med Microbiol. 1995 Dec;43(6):422-9. doi: 10.1099/00222615-43-6-422.
10
Reaction pattern of human anti-Mycoplasma pneumoniae antibodies in enzyme-linked immunosorbent assays and immunoblotting.人抗肺炎支原体抗体在酶联免疫吸附测定和免疫印迹中的反应模式。
J Clin Microbiol. 1986 Mar;23(3):517-22. doi: 10.1128/jcm.23.3.517-522.1986.

引用本文的文献

1
Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae.日本肺炎支原体感染的流行病学及大环内酯类耐药肺炎支原体的治疗策略
Front Microbiol. 2016 May 23;7:693. doi: 10.3389/fmicb.2016.00693. eCollection 2016.
2
Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays.通过定量酶免疫测定法分析芬兰健康人群中肺炎衣原体和肺炎支原体免疫球蛋白G和A抗体的患病率。
Clin Diagn Lab Immunol. 2000 Sep;7(5):734-8. doi: 10.1128/CDLI.7.5.734-738.2000.